Readable research linked to original sources

Articles

Browse normalized, publication-ready research with direct links to its evidence and source.

3 articles

Newest first

Research Article 2026CC BYFree full text

Vascular Contractile and Structural Properties in Diet-Induced Atherosclerosis-Prone CB1-LDL Receptor Double Knockout Animal Model

Kinga Shenker-Horváth, Zsolt Vass, Bálint Bányai, Stella Kiss, Kinga Bernadett Kovács, Judit Kiss +9 more

Biomedicines Europe PMC

Open article record in new tab ↗

Review Article 2025CC BYFree full text

Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management.

Raymond Rubianto Tjandrawinata, Dante Saksono Harbuwono, Sidartawan Soegondo, Nurpudji Astuti Taslim, Fahrul Nurkolis, Alfredo Caturano

Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have transformed type 2 diabetes mellitus (T2DM) management by promoting glucosuria, lowering glycated hemoglobin (HbA1c), blood pressure, and weight; however, their use is limited by genitourinary infections and ketoacidosis. Phytocannabinoids-bioactive compounds from Cannabis sativa-exhibit multi-target pharmacology, including interactions with cannab…

Pharmaceuticals

Review Article 2023CC BYFree full text

Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update.

Gabriella Dörnyei, Zsolt Vass, Csilla Berta Juhász, György L Nádasy, László Hunyady, Mária Szekeres +2 more

Metabolic syndrome is a complex disease state, which appears mostly as a consequence of an unhealthy, sedentary lifestyle. Metabolic complications include insulin resistance (IR), diabetes, dyslipidemia, hypertension, and atherosclerosis, impairing life standards and reducing life expectancy. The endocannabinoid system (ECS) has an important role in signalization processes, not only in the central nervous system,…

Biomedicines Europe PMC

Open article record in new tab ↗